Evaluation of the diagnostic value of serum-based proteomics for colorectal cancer

Table 3 Comparison of serum protein profiles between colorectal cancer group and healthy control group

Mass (m/z)	DAve	PTTA	PWKW	PAD	Ave1	Ave2
4210.57	536.3	0.00000308	0.00000149	0.066	700.27	1236.57
2932.56	22.98	0.00000635	< 0.000001	0.00721	28.61	51.6
2022.34	282.69	0.0000161	< 0.000001	< 0.000001	309.73	27.04
3192.08	26.53	0.0000333	0.0000105	0.000326	30.96	57.49
3883.65	31.52	0.000476	0.000129	0.00122	46.6	78.12
877.4	3.23	0.000645	0.000129	0.000683	5.93	9.16
1866.09	62.56	0.000826	0.000407	< 0.000001	83.77	21.21
2899.72	13.03	0.000997	0.000189	< 0.000001	38.31	25.28
7772.42	338.93	0.00141	0.00147	0.0503	594.88	933.81
3158.36	53.74	0.00284	0.000264	< 0.000001	62.18	115.92
2272.09	20.34	0.00284	0.0000451	< 0.000001	22.18	42.51
4645.79	22.93	0.00432	0.00483	0.231	57.18	80.11
4092.12	22.14	0.00577	0.0321	0.324	113.17	135.31
1778.9	7.03	0.00739	0.00672	< 0.000001	18.66	11.64
4268.05	27.62	0.00795	0.000333	< 0.000001	69.05	96.67
2952.92	27.19	0.0104	0.0265	0.232	70.78	97.97
3262.98	50	0.0116	0.00564	< 0.000001	69.12	119.11
1897.01	14.98	0.0183	0.0122	< 0.000001	41.59	26.61
2660.37	35.86	0.0197	0.0367	0.286	115.58	151.44

PTTA: P value of t-test; PWKW: P value of Wilcoxon; PAD: P value of Anderson-Darling test.